The Board of Directors of Morepen Laboratories Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2023 - Q4FY23 and FY2023.
The USFDA conducted an inspection of the API manufacturing facility, at Baddi, Himachal Pradesh, of Morepen Laboratories Limited and cleared on 24th March 2023 without any adverse observation i.e., No 483.
The Board of Directors of Morepen Laboratories Limited have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23, 9MFY23 at its board meeting.